0001689548-21-000011.txt : 20210217 0001689548-21-000011.hdr.sgml : 20210217 20210217165643 ACCESSION NUMBER: 0001689548-21-000011 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210212 FILED AS OF DATE: 20210217 DATE AS OF CHANGE: 20210217 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mastrocola Lauren CENTRAL INDEX KEY: 0001827639 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39620 FILM NUMBER: 21645741 MAIL ADDRESS: STREET 1: C/O PRAXIS PRECISION MEDICINES, INC. STREET 2: ONE BROADWAY, 16TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Praxis Precision Medicines, Inc. CENTRAL INDEX KEY: 0001689548 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE BROADWAY STREET 2: 16TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-949-2220 MAIL ADDRESS: STREET 1: ONE BROADWAY STREET 2: 16TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 wf-form4_161359894605862.xml FORM 4 X0306 4 2021-02-12 0 0001689548 Praxis Precision Medicines, Inc. PRAX 0001827639 Mastrocola Lauren C/O PRAXIS PRECISION MEDICINES, INC. ONE BROADWAY, 16TH FLOOR CAMBRIDGE MA 02142 0 1 0 0 Principal Accounting Officer Common Stock 2021-02-12 4 A 0 8200 0 A 20418 D Stock Option (Right to Buy) 52.53 2021-02-12 4 A 0 48700 0 A 2031-02-12 Common Stock 48700.0 48700 D Ms. Mastrocola was awarded 8,200 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. The restricted stock units vest in equal annual installments over a four-year period beginning on the one-year anniversary of the vesting commencement date of February 12, 2021. The restricted stock units may be settled only by delivering shares of the Issuer's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. The shares underlying this stock option vest over a four-year period, with 27,175 shares vesting on the one-year anniversary of the vesting commencement date of February 12, 2021 and the remaining 21,525 shares vesting in 36 equal monthly installments following such first anniversary, subject to the reporting person's continued service through each vesting date. /s/ Alex Nemiroff, as Attorney-in-Fact 2021-02-17